TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17228674

Group type: EXPERIMENTAL
Intervention: Bulge group (n=11)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protrusion group (n=9)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prolapsus group (n=10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 30
Study: 14623654

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Estrogen supplementation
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 10817026

Group type: EXPERIMENTAL
Intervention: FES-biofeedback
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intensive PFM exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 8888415

Group type: EXPERIMENTAL
Intervention: Experimental group (performed 175 trials on acquisition day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (performed 10 trials, sat quietly for 155 trials, then performed 10 more trials)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups (performed 20 trials on retention day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Experimental group (EEG data analysis)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (EEG data analysis)
Number of subjects: 61
Study: 1894676

Group type: EXPERIMENTAL
Intervention: Forearm gauntlet (Colles') cast, leaving the thumb free
Number of subjects: 392

Group type: COMPARATOR
Intervention: Conventional 'scaphoid' plaster incorporating the thumb
Number of subjects: 392
Study: 7299342

Group type: EXPERIMENTAL
Intervention: Individualised intervention (advice on diet, cigarette smoking, and physical activity)
Number of subjects: 3336

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 3336
Study: 31782589

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment of physician's choice (TPC)
Number of subjects: 0
Study: 31132055

Group type: EXPERIMENTAL
Intervention: Randomized visual objects with consistent temporal presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized visual objects with inconsistent temporal presentation (or jitter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual motion via a radial field of coherent central dot motion without jitter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual motion via a radial field of coherent central dot motion with jitter
Number of subjects: 0
Study: 28818518

Group type: EXPERIMENTAL
Intervention: Seladelpar 50 mg/day
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Seladelpar 200 mg/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 25782032

Group type: EXPERIMENTAL
Intervention: Oxybutynin patch
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 23855449

Group type: EXPERIMENTAL
Intervention: Health promotion intervention (10-week duration)
Number of subjects: 324
Study: 21314695

Group type: EXPERIMENTAL
Intervention: 1.5-hour alcohol training program
Number of subjects: 395

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 395
Study: 19601704

Group type: EXPERIMENTAL
Intervention: Tolterodine ER
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 411
Study: 17530980

Group type: EXPERIMENTAL
Intervention: High-velocity power training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional resistance training
Number of subjects: 0
Study: 15303242

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER 75 mg to 225 mg/day
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg to 50 mg/day
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 11834153

Group type: EXPERIMENTAL
Intervention: Intensive care therapy (ICT) in neurosurgical intensive care unit for the first 2 weeks after admission
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional care therapy (CCT) in ordinary ward
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intensive care therapy (ICT) for patients under 50 years
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intensive care therapy (ICT) for patients with GCS 6-8 on admission
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intensive care therapy (ICT) for patients with brain stem injury below mesencephalon
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intensive care therapy (ICT) for patients undergoing conservative therapy only
Number of subjects: 200
Study: 9647379

Group type: EXPERIMENTAL
Intervention: New covered needle catheter (Clisco needle)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ordinary disposable needles
Number of subjects: 10
Study: 7864619

Group type: EXPERIMENTAL
Intervention: Lunch with 431 kcal (low-fat, low-CHO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lunch with 844 kcal (high-fat, high-CHO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast, lunch, and afternoon snack totaling approximately 700 kcal (low)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast, lunch, and afternoon snack totaling approximately 1200 kcal (medium)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Breakfast, lunch, and afternoon snack totaling approximately 1700 kcal (high)
Number of subjects: 12
Study: 2680964

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee
Number of subjects: 45

Group type: COMPARATOR
Intervention: Regular coffee
Number of subjects: 45
Study: 938849

Group type: EXPERIMENTAL
Intervention: Sialography
Number of subjects: 169

Group type: COMPARATOR
Intervention: Scintigraphy
Number of subjects: 169
Study: 31625293

Group type: EXPERIMENTAL
Intervention: Sarpogrelate
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study: 28584072

Group type: EXPERIMENTAL
Intervention: Publication of the 2009 Appropriate Use Criteria (AUC) for myocardial perfusion imaging (MPI)
Number of subjects: 3072611

Group type: COMPARATOR
Intervention: Period from January 2000 to October 2005
Number of subjects: 3072611

Group type: COMPARATOR
Intervention: Period from November 2005 to June 2009
Number of subjects: 3072611

Group type: COMPARATOR
Intervention: Period from March 2014 to December 2015
Number of subjects: 3072611
Study: 25465508

Group type: EXPERIMENTAL
Intervention: Horse Riding Simulation (HRS) exercise for 20 min, 5 times a week, for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Horse Riding Simulation (HRS) exercise
Number of subjects: 30
Study: 23796204

Group type: EXPERIMENTAL
Intervention: Cetuximab 250 mg/m²
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cetuximab 250 mg/m² with paclitaxel 80 mg/m²
Number of subjects: 39
Study: 21763419

Group type: COMPARATOR
Intervention: Inspired oxygen concentration of 30%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Inspired oxygen concentration of 50%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Inspired oxygen concentration of 80%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hemoglobin
Number of subjects: 45
Study: 19406871

Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg/day
Number of subjects: 1252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1252
Study: 17952841

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Pioglitazone + Simvastatin (PIO+SIMVA)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Simvastatin (SIMVA)
Number of subjects: 125
Study: 15302980

Group type: EXPERIMENTAL
Intervention: Nifedipine retard
Number of subjects: 199

Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 199
Study: 11149479

Group type: EXPERIMENTAL
Intervention: Jumping intervention (100, two-footed jumps off 61-cm boxes, three times per week for 7 months)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (nonimpact stretching exercises, three times per week for 7 months)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Jumping intervention
Number of subjects: 89
Study: 9482764

Group type: EXPERIMENTAL
Intervention: OKG bolus (23.7 +/- 2.1 d)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: OKG administration
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 30 g OKG/d
Number of subjects: 54

Group type: COMPARATOR
Intervention: OKG (10, 20, or 30 g/d)
Number of subjects: 54
Study: 7744131

Group type: EXPERIMENTAL
Intervention: nimesulide 200mg/day
Number of subjects: 200

Group type: COMPARATOR
Intervention: etodolac 600mg/day
Number of subjects: 200
Study: 2910989

Group type: EXPERIMENTAL
Intervention: Propranolol administration (0.1 mg/kg iv)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Active standing
Number of subjects: 45
Study: 972268

Group type: EXPERIMENTAL
Intervention: Gentamicin and Tobramycin (80 mg intravenous injection)
Number of subjects: 6
Study: 31161661

Group type: EXPERIMENTAL
Intervention: Hypertensive group
Number of subjects: 201
Study: 29752265

Group type: EXPERIMENTAL
Intervention: Synthetic transcriptional reporter designed for PhoB activity, utilizing both stable and destabilized variants of green fluorescent protein (GFP).
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Synthetic transcriptional reporter in different members of the Proteobacteria.
Number of subjects: 83
Study: 26683756

Group type: EXPERIMENTAL
Intervention: Exenatide (5 mcg twice daily for 1 month, then 10 mcg twice daily for 2 months)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 32
Study: 24292873

Group type: EXPERIMENTAL
Intervention: Prophylactic noninvasive ventilation (NIV), applied intermittently during 6 h per day for 48 h following surgery
Number of subjects: 360

Group type: COMPARATOR
Intervention: Conventional postoperative treatment without NIV
Number of subjects: 360
Study: 23031322

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) guided by real-time continuous glucose monitoring (CGM), n = 63
Number of subjects: 174

Group type: COMPARATOR
Intervention: Algorithm guided by selective arterial blood glucose measurements with simultaneously blinded CGM for 72 hours, n = 111
Number of subjects: 174
Study: 21060042

Group type: EXPERIMENTAL
Intervention: Femtosecond laser flap creation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mechanical microkeratome flap creation
Number of subjects: 21
Study: 17595417

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Functional plus Resistance Training (FRT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Walking Speed
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Single-leg Balance
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Body Composition
Number of subjects: 32
Study: 16213340

Group type: EXPERIMENTAL
Intervention: Internal jugular vein (IJV) catheterization
Number of subjects: 45

Group type: COMPARATOR
Intervention: Subclavian vein (SV) catheterization
Number of subjects: 45
Study: 12399793

Group type: EXPERIMENTAL
Intervention: Etomidate (0.1 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Midazolam (0.033 mg/kg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 46

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Etomidate and Midazolam
Number of subjects: 46
Study: 10460116

Group type: EXPERIMENTAL
Intervention: Supple elastic TE orthosis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Semi-rigid TE orthosis
Number of subjects: 10

Group type: COMPARATOR
Intervention: All three types of TE orthoses
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: TE orthoses (general)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Supple elastic orthosis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Semi-rigid orthosis
Number of subjects: 10
Study: 7497502

Group type: EXPERIMENTAL
Intervention: Transradial stenting (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transfemoral stenting (Group B)
Number of subjects: 60
Study: 2699986

Group type: EXPERIMENTAL
Intervention: Increased dialysate flow rate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 liter exchange volume
Number of subjects: 24
Study: 961545

Group type: EXPERIMENTAL
Intervention: Copper bracelets
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo bracelets (amodised aluminum resembling copper)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Copper bracelet worn around the wrist
Number of subjects: 300
Study: 31180234

Group type: EXPERIMENTAL
Intervention: Alternate Nostril Breathing (ANB)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Foot Reflexology (FR)
Number of subjects: 11
Study: 28661758

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 3823

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3823

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 3823

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 3823
Study: 25659070

Group type: EXPERIMENTAL
Intervention: Local anaesthetic infiltration and standard care
Number of subjects: 638

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 638
Study: 23700057

Group type: EXPERIMENTAL
Intervention: Day 15 marrow response
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisone response
Number of subjects: 0
Study: 21830944

Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 18678568

Group type: EXPERIMENTAL
Intervention: Functional thumb orthosis used daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (orthosis used only during evaluation)
Number of subjects: 40
Study: 16863699

Group type: EXPERIMENTAL
Intervention: Active trigger points in ETTH patients
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Latent trigger points in ETTH patients
Number of subjects: 10

Group type: COMPARATOR
Intervention: Latent trigger points in control subjects
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of active TrPs between ETTH patients and controls
Number of subjects: 10
Study: 12582219

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (30 mg for 24 hours)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg for 24 hours)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (300 mg/24 hours with food)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (300 mg/24 hours fasting)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (with food)
Number of subjects: 12
Study: 11054441

Group type: EXPERIMENTAL
Intervention: Paclitaxel 54 mg/m(2) and Carboplatin AUC 6 mg.min/mL
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Paclitaxel 67.5 mg/m(2) and Carboplatin AUC 6 mg.min/mL
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Paclitaxel 81 mg/m(2) and Carboplatin AUC 6 mg/mL
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Paclitaxel 54.5 mg/m(2) to 94.5 mg/m(2)
Number of subjects: 58
Study: 9085389

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at points previously used for anti-smoking (test group, TG)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acupuncture treatment at points assumed to have no effect for smoking cessation (control group, CG)
Number of subjects: 46
Study: 8210832

Group type: EXPERIMENTAL
Intervention: Post myocardial infarction survival trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multicentre heart failure study
Number of subjects: 0
Study: 3546149

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg b.i.d. by oral route
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Ofloxacin 300 mg b.i.d. by oral route
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Ofloxacin 400 mg b.i.d. by oral route
Number of subjects: 1436

Group type: EXPERIMENTAL
Intervention: Ofloxacin (all dosages combined)
Number of subjects: 1436
Study: 31453531

Group type: EXPERIMENTAL
Intervention: SPRI-P (pool-based intervention)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: SPRI-L (land-based intervention)
Number of subjects: 73
Study: 27048333

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 25753825

Group type: EXPERIMENTAL
Intervention: Anatomic Ligament Repair (ALR)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Triangular Ligament Reconstruction (TLR)
Number of subjects: 64
Study: 23857248

Group type: EXPERIMENTAL
Intervention: Preladenant 10 mg BID for 5 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preladenant 100 mg BID for 5 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg on day 5
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19952825

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 0
Study: 18823310

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG) treatment
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG) treatment in adults
Number of subjects: 73
Study: 16082393

Group type: EXPERIMENTAL
Intervention: Schirmer's test (cutoff point of 5 mm)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Schirmer's test (cutoff point of 10 mm)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Phenol red thread test (cutoff point of 10 mm)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Phenol red thread test (cutoff point of 20 mm)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Agreement between Schirmer's test and phenol red thread test
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Symptoms of dry eyes
Number of subjects: 103
Study: 12631257

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ibandronate 4 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 44
Study: 10994765

Group type: EXPERIMENTAL
Intervention: High-calcium skim milk
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Potassium-enriched high-calcium skim milk
Number of subjects: 38

Group type: COMPARATOR
Intervention: Skim milk (control)
Number of subjects: 38
Study: 8557126

Group type: EXPERIMENTAL
Intervention: Long-acting GnRH analogues
Number of subjects: 100

Group type: COMPARATOR
Intervention: Short-acting GnRH analogues
Number of subjects: 100
Study: 1587405

Group type: EXPERIMENTAL
Intervention: Electrical acustimulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham acustimulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study: 3159583

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg ketanserin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (10 ml saline)
Number of subjects: 6
Study: 31166976

Group type: EXPERIMENTAL
Intervention: Gabapentin (initiated at 300 mg/day, titrated to a maximum of 1800 mg/day)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 98
Study: 29626068

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 22351
Study: 27086024

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.05%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical methylprednisolone 0.5%
Number of subjects: 40
Study: 24096438

Group type: EXPERIMENTAL
Intervention: Double-balloon catheter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dinoprostone (10-mg intra-vaginal insert)
Number of subjects: 0
Study: 23128405

Group type: EXPERIMENTAL
Intervention: Perioperative selective decontamination of the digestive tract (SDD)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 20826630

Group type: EXPERIMENTAL
Intervention: GLUFRU (1.2 g glucose/min + 0.8 g fructose/min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Glucose alone (1.2 g glucose/min)
Number of subjects: 7
Study: 18617257

Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention (participants who increased step counts)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: 10,000 Steps Ghent intervention (participants who did not increase step counts)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Comparison community
Number of subjects: 440
Study: 15968765

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) immediately post-operatively
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 12087347

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with angiotensin II at 1 pmol/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (100, 250, and 1000 ng/min) with angiotensin II at 5 pmol/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candesartan (single dose) or vitamin C (coinfusion)
Number of subjects: 0
Study: 10689211

Group type: EXPERIMENTAL
Intervention: Once-daily cefdinir 600 mg
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Twice-daily cefdinir 300 mg
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Twice-daily cefuroxime axetil 250 mg
Number of subjects: 1045
Study: 9034133

Group type: EXPERIMENTAL
Intervention: Alkali (NaHCO3)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 8
Study: 8477290

Group type: EXPERIMENTAL
Intervention: Restrained eaters under anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restrained eaters under relaxed conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrestrained eaters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anxious hungry restrained subjects
Number of subjects: 0
Study: 3520389

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion with micropump CPI 9100 Lilly
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intensified insulin therapy with three daily doses of MC rapid insulin, two of which associated with MC intermediate insulin
Number of subjects: 10